Lumexa Imaging Holdings, Inc. (LMRI) vs Tandem Diabetes Care, Inc. (TNDM)
Lumexa Imaging Holdings, Inc. and Tandem Diabetes Care, Inc. are both Medical Devices companies. Tandem Diabetes Care, Inc. is the larger, with a market value of $1.1B against $949.2M — 1.1× the size. Lumexa Imaging Holdings, Inc. has the higher net margin (−2.78% vs −6.08%) and the higher return on invested capital (48.1% vs −10.3%). Across the 16 metrics below, Lumexa Imaging Holdings, Inc. leads on 13 and Tandem Diabetes Care, Inc. on 3.
Valuation
Profitability
| Metric | LMRI | TNDM | Medical Devices median |
|---|---|---|---|
| Gross margin | 63.41% | 56.01% | 56.01% |
| Operating margin | 61.03% | (4.40%) | (15.03%) |
| Net margin | (2.78%) | (6.08%) | (20.40%) |
| Free cash flow margin | 0.83% | (2.56%) | (7.24%) |
| Return on equity | 0.00% | (48.03%) | (15.32%) |
| Return on assets | (5.51%) | (6.24%) | (19.72%) |
| Return on invested capital | 48.10% | (10.33%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack